Biopharmaceutical Contract Manufacturing Market Biopharmaceutical Contract Manufacturing Learn how outsourcing trends in biopharma m ...
NEW YORK, NY / ACCESS Newswire / February 10, 2025 / If you suffered a loss on your GSK plc (NYSE:GSK) investment and want to learn about a ...
Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has bee ...
Arizona Attorney General Kris Mayes on Thursday sued drug producer GlaxoSmithKline (GSK) for harm done to asthma patients by discontinuing a long-time product.
LOS ANGELES, CA / ACCESS Newswire / February 10, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of ...
International drug giant GSK plc is moving its vaccine R&D and infectious disease teams to Cambridge from Maryland, and plans to expand its footprint here.
Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased GSK plc. ("GSK" or the "Company") (NYSE: GSK) American Depositary Receipts ...
The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the ...
It spreads through inhalation or contact with the fluids from an infected person's coughs or sneezes. 2 While often linked to ...
GSK, a UK-based biopharma, reported strong 2024 results, with a promising shift toward specialty medicines. Read why I ...
The report provides insights into GSK's tech activities, including its digital transformation strategies, its innovation programs, and its technology ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results